Ergoteles’s Ligand Pharmaceuticals LGND Stock Holding History

Ergoteles’s Portfolio LGND Stock Details LGND Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$204K	Sell
2022 Q4	$660K	Buy
2022 Q3	$516K	Buy
2021 Q3	–	Sell
2021 Q2	$314K	Sell
2021 Q1	$566K	Buy